Get the full picture
Sign in to uncover key details.
TRexBio
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
269 E Grand Ave Ste 300, South San Franc...Phone Number
(650) 567-5582Website
trex.bioRevenue
-Industry
About TRexBio
TRexBio, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, founded in 2018. The company develops immunoregulatory medicines designed to restore immune balance in autoimmune and inflammatory diseases by leveraging its proprietary Deep Biology Platform, which maps regulatory T cell function in human tissue to identify novel drug targets. Its lead candidate, TRB-061, is a TNFR2 agonist in clinical development for atopic dermatitis, alongside a growing pipeline of preclinical programs and strategic collaborations with major pharmaceutical partners.Explore more
TRexBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TRexBio
Compare insights from companies similar to TRexBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
TRexBio Tech Stack
A closer look at the technologies used by TRexBio
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TRexBio
Sign Up For FreeTo access detailed company insights
TRexBio, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, founded in 2018. The company develops immunoregulatory medicines designed to restore immune balance in autoimmune and inflammatory diseases by leveraging its proprietary Deep Biology Platform, which maps regulatory T cell function in human tiss... Read More
